Additional file 1 of Change of histone H3 lysine 14 acetylation stoichiometry in human monocyte derived macrophages as determined by MS-based absolute targeted quantitative proteomic approach: HIV infection and methamphetamine exposure

Additional file 1: Table S1. The MRM transitions (Q1/Q3) monitored for histone H3 K9[Poy]K14[Poy], K9[Poy]K14[Poy]-heavy, K9[Poy]K14[Ac] and K9[Poy]K14[Ac]-heavy peptides investigated in the present study, with manually optimized declustering potential (DP), collision energy (CE) and cell exit potential (CXP). Table S2. LC-MS/MS method validation – peptide results. Table S3. LC-MS/MS method validation – transitions results. Table S4. The LC-MS/MS results for all investigated donors' CIC, CIM and MIM samples with absolute abundances of the endogenous K9[Poy]K14[Ac] and K9[Poy]K14[Poy]. Table S5. MRM transition ratios for standard dilutions and donors’ samples. Table S6. Stoichiometry of H3K14[Ac] in donors’ CIC, CIM and MIM samples.